(Q35329457)

English

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures

scientific article published on June 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures (English)

1 reference

Europe PubMed Central

7 August 2017

vascular disease

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

S. M. Grant

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1379160

20 September 2022

K. L. Goa

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1379160

20 September 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1379160

20 September 2022

publication date

1 June 1992

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

43

1 reference

Europe PubMed Central

7 August 2017

6

1 reference

Europe PubMed Central

7 August 2017

889-924

1 reference

Europe PubMed Central

7 August 2017

https://scigraph.springernature.com/pub.10.2165/00003495-199243060-00008

0 references

Antiplatelet effect of iloprost

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of limb threatening ischaemia with intravenous iloprost: a randomised double-blind placebo controlled study. U.K. Severe Limb Ischaemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of drugs on the TXA2/PGI2 balance and on the atherogenic index in myocardial ischemia in dogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of iloprost and indomethacin with the cardiac effects of isoprenaline, ouabain and trapidil.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular disease in diabetes: pathophysiological mechanisms and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arachidonic acid cascade and the generation of ischemia- and reperfusion-induced ventricular arrhythmias

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost improves femoro-distal graft flow after a single bolus injection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostacyclin analogue iloprost decreases thrombolytic potential of tissue-type plasminogen activator in canine coronary thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does prostacyclin analogue Iloprost change blood rheology? Results from a double blind trial with intravenous application in diabetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental endotoxemia in the rat: efficacy of prostacyclin or the prostacyclin analog iloprost.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in some aspects of platelet function with improvement of glycaemic control over 6 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost and risk of thromboembolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biotransformation of the stable prostacyclin analogue, iloprost, in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in the preservation of ischemically impaired renal transplants of pigs by iloprost (ZK 36 374).

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostacyclins are only weak antagonists of coronary vasospasm induced by authentic thromboxane A2 and serotonin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost (ZK 36374) enhances recovery of regional myocardial function during reperfusion after coronary artery occlusion in the pig.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of radio-labeled iloprost in elderly volunteers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost in peripheral vascular disease--platelet function and clinical outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Whole blood white cell aggregation: a novel technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential therapeutic mechanisms of stable prostacyclin (PGI2)-mimetics in severe peripheral vascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemodynamic effects of iloprost, a prostacyclin analog

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of selective [3H]iloprost binding sites on human platelet membranes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved recovery of cardiac function after 24 h of hypothermic arrest in the isolated rat heart: comparison of a prostacyclin analogue (ZK 36 374) and a calcium entry blocker (diltiazem)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of iloprost in the stunned canine myocardium

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defective fibrinolytic response in atherosclerotic patients--effect of iloprost and its possible mechanism of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost (ZK36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Per-operative topical administration of ZK 36 374 (Iloprost) acts favorably on patency of small artery anastomoses in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical benefits of iloprost, a stable prostacyclin (PGI2) analog, in severe peripheral arterial disease (PAD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin-aldosterone system in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of PGI2 analog iloprost on myocardial infarct size, regional myocardial blood flow, and platelet function in rabbits with coronary artery occlusion followed by reperfusion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a synthetic prostacyclin analogue on renin release in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained protection by iloprost of the porcine heart in the acute and chronic phases of myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of human and animal platelet aggregation by a new prostacyclin analog

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Iloprost, a stable prostacyclin derivative, in stage 4 arterial occlusive disease. A placebo-controlled multicenter study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of iloprost in patients with chronic renal failure and on maintenance haemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local effects of the prostacyclin analogue iloprost on cutaneous blood supply and oedema formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for high affinity prostacyclin binding sites in vascular tissue: Radioligand studies with a chemically stable analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet prostacyclin binding in coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limitation of myocardial unperfused area and necrotic zone 24 hours and 7 days after coronary artery ligation in rats by the stable prostacyclin analogue iloprost.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the vasodepressor action of ZK 36 374, a stable prostacyclin derivative, PGI2 and PGE1 with their effect on platelet aggregation and bleeding time in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet hyperaggregability occurring during prolonged continuous intravenous infusions of prostacyclin analogue ZK 36374

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a synthetic prostacyclin in extracorporeal circulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective effect of a prostacyclin-mimetic on the ischaemic-reperfused rabbit myocardium.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholestyramine treatment of type IIa hypercholesterolaemia normalizes platelet reactivity against prostacyclin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Desensitization of iloprost responsiveness in human platelets follows prolonged exposure to iloprost in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical management of heparin-associated thrombocytopenia. Strategies in the treatment of venous and arterial thromboembolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selection and procurement of combined heart and lung grafts for transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of stable prostacyclin analogue ZK 36 374 to treat severe lower limb ischaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histochemical and biochemical studies on the effect of the prostacyclin derivative iloprost on CCl4-induced lipid peroxidation in rat liver and its significance for hepatoprotection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of prostacyclin analogue-containing suture for the prevention of postoperative venous thrombosis in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible beta-adrenoceptor modulating effect of ZK 36 374 a stable analogue of carbacyclin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of the stable prostacyclin analogue ZK 36374 on experimental coronary thrombosis in the pig

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction between leukotriene D4 and adenosine or iloprost in the isolated working guinea-pig heart: prevention of the leukotriene D4 effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental cerebral vasospasm: resolution by iloprost

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effect of iloprost on early pulmonary function after lung preservation with modified eurocollins solution

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac electrophysiological effects of prostacyclin analogues, 7-oxo-PGI2 and iloprost

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of iloprost, a stable prostacyclin analog, on exercise capacity and platelet aggregation in stable angina pectoris

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ZK 36-374, a stable analog of prostacyclin, prevents acute hypoxic pulmonary hypertension in the dog.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relaxation of isolated human pulmonary muscle preparations with prostacyclin (PGI2) and its analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central haemodynamic and antiplatelet effects of iloprost--a new prostacyclin analogue--in acute myocardial infarction in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost in Prinzmetal's angina

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of new chemically and metabolically stable prostacyclin analogues (iloprost and ZK 96480) on early consequences of a transient cerebral oligemia, in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute hemodynamic (systemic and renal) and humoral effects of three increasing doses of iloprost in essential hypertensives

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a prostacyclin derivative (iloprost) on regional blood flow, sympathetic nerve activity, and baroreceptor reflex in the conscious rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374).

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandins

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostacyclin and iloprost do not affect action of standard dose heparin on haemostatic function during haemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb. A Scandinavian-Polish placebo controlled, randomised multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet sensitivity to a prostacyclin analogue in systemic sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiplatelet effects of intravenous iloprost in patients with peripheral arterial obliterative disease. A placebo-controlled dose-response study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with iloprost of critical ischemia of the lower limbs associated with cardiac insufficiency. Study of interaction with the pharmacokinetics of digoxin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of tissue-type plasminogen activator during acute myocardial infarction in men. Effect of a prostacyclin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relaxing activity of iloprost and prostaglandin E2 in the isolated various smooth muscle strips of the rabbit

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostacyclin—Antiarrhythmic or Arrhythmogenic? Comparison of the Effects of Intravenous and Intracoronary Prostacyclin and ZK36374 During Coronary Artery Occlusion and Reperfusion in Anaesthetised Greyhounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myocardial ischemia during intravenous prostacyclin administration: hemodynamic findings and precautionary measures

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective actions of a stable prostacyclin analog in ischemia induced membrane damage in rat myocardium

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eicosanoids and susceptibility to ventricular arrhythmias during myocardial ischaemia and reperfusion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of platelet aggregation and antagonism of vasopressin-induced ECG changes in primates by a carboprostacyclin analogue, ZK 36374

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infusion of a stable prostacyclin analogue, iloprost, to patients with peripheral vascular disease: lack of antiplatelet effect but risk of thromboembolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of the prostacyclin analogue iloprost in the treatment of patients with critical limb ischaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of iloprost (ZK36374) versus aspirin in preventing heparin-induced platelet activation during cardiac operations

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Treatment of Raynaud's phenomenon in scleroderma with a new stable prostacyclin derivative]

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a prostacyclin analog iloprost on kidney function, renin-angiotensin and kallikrein-kinin systems, prostanoids and catecholamines in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory Effects of ZK 36374, a Stable Prostacyclin Analogue, on Adhesion of Rabbit Platelets to Damaged Aorta and Serotonin Release by Adherent Platelets

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracorporeal circulation in a patient with heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of a stable prostacyclin analogue (iloprost) and cyclooxygenase inhibition on angiotensin-II in the perfused human placenta.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost antagonizes endothelin-induced vasoconstriction in macro- and microcirculation

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet antiaggregatory substances inhibit arachidonic acid induced coronary constriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temporary inhibition of platelet function with iloprost (ZK36374) preserves canine platelets during extracorporeal membrane oxygenation

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thromboxane A2 inhibitors and iloprost prevent angiotensin II-induced oedema in the isolated perfused rat lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of iloprost on in vivo and in vitro platelet function in patients with peripheral vascular disease (PVD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of iloprost in patients with hepatic dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of oxygen-centered free radical formation by the stable prostacyclin-mimetic iloprost (ZK 36 374) in acute myocardial ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of iloprost in patients with severe peripheral arterial occlusive disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retrospective comparison of iloprost with other treatments for secondary Raynaud's phenomenon

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of a prostacyclin analog, iloprost, as an adjunct to pulmonary preservation with Euro-Collins solution

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost preserves kidney function against anoxia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of extracorporeal platelet deposition in cardiopulmonary bypass: effects of ZK 36374, a prostacyclin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development, validation and practical use of a sensitive and specific radioimmunoassay for the determination of iloprost

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in human neutrophil chemotaxis by the prostacyclin analogue iloprost

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Action of the stable prostacyclin analogue iloprost on microvascular tone and -permeability in the hamster cheek pouch

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of effect of a 24-hour infusion of iloprost in intermittent claudication

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proper donor selection for heart-lung transplantation. The Stanford experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and biotransformation of the prostacyclin analogue, ZK 36 374, in the monkey (Macaca fascicularis)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost binding and inhibition of aggregation in platelet rich plasma. Differences between normal and type IIa hypercholesterolemic subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost infusion decreases skeletal muscle ischemia-reperfusion injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effect of treatment with a prostacyclin analogue in severe peripheral atherosclerosis. A case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet function studies during and after infusions of ZK 36374, a stable prostacyclin analogue, to healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypotension in response to iloprost, a prostacyclin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute reversible reduction of PGI2 platelet receptors after iloprost infusion in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transdermally applied iloprost (ZK36-374) decreases whole blood platelet aggregation in normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further studies on the antiarrhythmic effect of iloprost

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic antiplatelet and antithrombotic effects of a prostacyclin analogue (iloprost) combined with a thromboxane antagonist (sulotroban) in guinea pigs and rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of PGI2 and its stable analog on platelet function in hyperlipoproteinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombotic profile of iloprost in experimental models of in vivo platelet aggregation and thrombosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-associated thrombocytopenia: management of patients for open heart surgery. Case reports describing the use of iloprost.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprost

1 reference

https://pubmed.ncbi.nlm.nih.gov/1379160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199243060-00008

1 reference

Europe PubMed Central

7 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35329457&oldid=2143835282"